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EASILY MISSED?
Acute Charcot foot
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This is one of a series of occasional articles highlighting conditions that
may be more common than many doctors realise or may be missed at
first presentation. The series advisers are Anthony Harnden, university
lecturer in general practice, Department of Primary Health Care,
University of Oxford, and Richard Lehman, general practitioner, Banbury.
To suggest a topic for this series, please email us at
easilymissed@bmj.com
A 38 year old man was referred by his general practitioner to
our diabetes foot clinic with a swollen red foot (fig 1⇓). He had
had type 1 diabetes for 25 years, complicated with retinopathy,
peripheral neuropathy, and nephropathy, and was being worked
up for dialysis following a failed pancreas-kidney transplant.
The absence of pain together with preserved pulses and intact
skin raised a suspicion of acute Charcot foot. A plain radiograph
of the foot showed fractures through the necks of the first three
metatarsals (fig 2⇓). We offloaded the foot in a total contact
cast and advised the patient to limit weight bearing. Magnetic
resonance imaging (MRI) subsequently confirmed
neuroarthropathic changes of acute Charcot (fig 3⇓).
What is acute Charcot foot?
Charcot’s neuroarthropathy is a destructive process of bone and
joint, typically seen in a foot that has lost its protective sensory
innervation. The classic description of this disabling condition
by Jean-Martin Charcot in 1883 was in patients with tabes
dorsalis, but nowadays most cases of Charcot foot occur as a
complication of diabetes mellitus. The chronic stage of the
disease is easily recognisable, but the acute phase can present
a diagnostic challenge.1 In a recent series the diagnosis of acute
Charcot foot was missed before specialist referral in 19 of 20
patients.2 In another report, referring clinicians failed to diagnose
Charcot foot in 19 of 24 cases seen in a specialist diabetes foot
clinic.3
Why is acute Charcot foot missed?
The acute phase of a Charcot foot may not be considered or
may be mistaken for more common causes of leg or foot
swelling, such as cellulitis, gout, deep venous thrombosis, or
sprains.2 The misdiagnosis of ankle sprain is particularly
common if the patient recalls a history of trivial injury. Standard
radiographs may show no abnormalities at this stage,
contributing to delays in diagnosis.3
Why does this matter?
The delay in correct diagnosis is harmful because during the
acute phase the foot bones are vulnerable to fragmentation and
dislocation.1 If the patient continues to walk on an insensitive
foot, this may lead—sometimes within weeks—to irreversible
deformities, such as mid-foot dislocation or collapse and
inversion of the plantar arch, the so called rocker-bottom foot.
These deformities may, in turn, predispose to skin ulcer, an
established risk factor for amputation.4 If the disease is
diagnosed in the acute phase, bone and joint damage can largely
be prevented by avoiding weight bearing.1 Timely recognition
may also identify patients with diabetes who are at increased
risk of mortality owing to the severe neuropathy associated with
Charcot foot.5 In one series, patients with acute Charcot foot or
neuropathic foot ulcers had a 5-year mortality rate of 40%.5
Mortality may relate to co-existent renal disease in some
patients, but neuropathy is also believed to independently
increase cardiovascular risk by promoting vascular calcification.6
How is acute Charcot foot diagnosed?
Clinical features
The usual presentation is a red, swollen, warm foot in which
pulses are preserved (fig 1). Owing to neuropathy, pain is not
always present or is less than expected for the severity of the
clinical findings. Longstanding diabetes, either type 1 or type
2, or a history of renal transplantation confer a particularly high
risk.7 The patient may be thought at this stage to have gout,
ankle sprain, or deep venous thrombosis, but the most common
misdiagnosis is infection. The presence of an ulcer favours the
diagnosis of cellulitis or osteomyelitis, particularly if this can
be probed to bone. Absence of skin break, stable insulin
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Key points
• Suspect acute Charcot foot in a patient with diabetes and neuropathy who presents with a swollen warm foot
• If acute Charcot foot is suspected, arrange for offloading of the foot (to minimise further damage) and refer to a specialist foot clinic
immediately
• Plain radiographs may be normal in the early stages of the disease
• Magnetic resonance imaging should be considered when the suspicion of acute Charcot foot is high
How common is acute Charcot foot?
• The true incidence of acute Charcot foot is difficult to establish, because few population based studies have been published and no
diagnostic criteria have been universally agreed
• The reported annual incidence of Charcot arthropathy in patients with diabetes has varied from 0.3% in population studies11 to 12.0%
in referral centre studies7
• Studies in specialist units report that Charcot arthropathy was present in 9% of patients with diabetic neuropathy and foot ulcer12 and
in 12% of diabetic patients who had received pancreas-kidney transplants7
requirements, and normal white blood cell counts or C-reactive
protein levels are more suggestive of acute Charcot than
infection.8 Neuro-arthropathy and infection are, however, not
mutually exclusive and if any doubt exists the patient should
be treated for both conditions until the true diagnosis is
established.8
Investigations
Standard radiographs are an important first line investigation.
The finding of fractures or bony misalignment in the absence
of obvious trauma is highly suggestive of Charcot foot (fig 2).
The initial radiograph may be normal, but this should not divert
from the diagnosis if the clinical suspicion is high.3 A
radioisotope bone scan or MRI can show bone disease even
when radiographic changes are subtle (fig 3). The choice
between nuclear imaging and MRI is largely based on local
availability and experience.9Bone scan has less specificity than
MRI (25-38% v 80-100%), but the diagnostic sensitivity of
either test approaches 100%.10 The mid-foot region is the most
common site of disease, although hind-foot involvement carries
a particularly severe prognosis owing to the risk of ankle
instability. MRI is the investigation of choice in patients with
ulcers and a high probability of deep infection. However, the
differentiation of Charcot from osteomyelitis may occasionally
be difficult even with MRI.9 10
How is acute Charcot foot managed?
If acute Charcot foot is suspected, seek urgent referral to a
specialist foot clinic and advise patients to avoid weight bearing
pending evaluation8 Early offloading of the foot with total
contact casting is the gold standard of treatment.9 Casting is
usually needed for three to six months, and healing is indicated
by resolution of oedema and warmth. Radiographic or MRI
evidence of healing assists the clinical decision to discontinue
casting and transfer the patient into a bespoke shoe.9 A lifelong
programme of patient education and routine foot care should
form an essential component of treatment. Reconstructive
surgery is currently reserved for patients in whom attempts at
conservative care have failed to prevent major deformities.
Earlier surgical intervention could nonetheless be considered
for patients with ankle disease owing to the often limited success
of conservative measures in this form of disease.9
Bisphosphonates have been proposed to counteract the excess
bone turnover that characterises the acute Charcot foot, but the
evidence for their benefit is still inconclusive.9
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Figures
Fig 1 Acute Charcot foot
Fig 2 Plain radiograph of the foot showing fractures through the necks of the first three metatarsals
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Fig 3 Axial T1 weighted MRI showing pathological fractures through the necks of the first three metatarsals (arrows) with
oedema in metatarsal shafts and lateral cuneiform bones (arrow heads). These features, in a patient with diabetes and no
history of trauma, suggest acute Charcot foot
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